Kinetics of silica nanoparticles in the human placenta

Nanotoxicology

Volumn 9, Issue S1, 2015, Pages 79-86

  Poulsen, Marie Sonnegaard ^a   Mose, Tina ^a   Maroun, Lisa Leth ^b   Mathiesen, Line ^a   Knudsen, Lisbeth Ehlert ^a   Rytting, Erik ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

BeWo cells; in vitro; Nanotoxicology; Placental perfusion; Transport

Indexed keywords

PHENAZONE; SILICA NANOPARTICLE; NANOPARTICLE; SILICON DIOXIDE;

APPARENT PERMEABILITY; ARTICLE; BIOCOMPATIBILITY; CANCER CELL CULTURE; CELL TRANSPORT; CELL VIABILITY; CHORIOCARCINOMA; CONFOCAL MICROSCOPY; CYTOTOXICITY; FEMALE; FLUORESCENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; MTT ASSAY; NANOTOXICOLOGY; PARTICLE SIZE; PLACENTA; PLACENTA PERFUSION; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; FETOMATERNAL TRANSFUSION; KINETICS; METABOLISM; PREGNANCY; TRANSPORT AT THE CELLULAR LEVEL;

ANTIPYRINE; BIOLOGICAL TRANSPORT; CELL LINE; CELL SURVIVAL; FEMALE; HUMANS; KINETICS; MATERNAL-FETAL EXCHANGE; NANOPARTICLES; PLACENTA; PREGNANCY; SILICON DIOXIDE;

EID: 84902115036     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2013.812259     Document Type: Article

References (39)

1. Ala-Kokko TI, Myllynen P, Vähäkangas K. 2000. Ex vivo perfusion of the human placental cotyledon: implications for anesthetic pharmacology. Int J Obstet Anesth 9:26-38.
2. Bode CJ, Jin H, Rytting E, Silverstein PS, Young AM, Audus KL. 2006. In vitro models for studying trophoblast transcellular transport. Methods Mol Med 122:225-239.
3. Buerki-Thurnherr T, von Mandach U, Wick P. 2012. Knocking at the door of the unborn child: engineered nanoparticles at the human placental barrier. Swiss Med Wkly 142:w13559.
4. Cartwright L, Poulsen MS, Nielsen HM, Pojana G, Knudsen LE, Saunders M, et al. 2012. In vitro placental model optimization for nanoparticle transport studies. Int j nanomedicine 7:497-510.
5. Chen Z-Z, Cai L, Dong X-M, Tang H-W, Pang D-W. 2012. Covalent conjugation of avidin with dye-doped silica nanopaticles and preparation of high density avidin nanoparticles as photostable bioprobes. Biosens Bioelectron 37:75-81.
6. Dusinska M, Fjellsbo LM, Heimstad E, Harju M, Bartonova A, Tran L, et al. 2009a. Development of methodology for alternative testing strategies for the assessment of the toxicological profile of nanopar-ticles used in medical diagnostics. NanoTEST - EC FP7 project. J Phys Conf Ser 170:012039.
7. Dusinska M, Fjellsbø L, Magdolenova Z, Rinna A, Runden Pran E, Bartonova A, et al. 2009b. Testing strategies for the safety of nanoparticles used in medical applications. Nanomedicine (London) 4: 605-607.
8. Fisichella M, Dabboue H, Bhattacharyya S, Saboungi ML, Salvetat JP, Hevor T, et al. 2009. Mesoporous silica nanoparticles enhance MTT formazan exocytosis in HeLa cells and astrocytes. Toxicol in Vitro 23: 697-703.
9. Galagudza M, Korolev Postnov Naumisheva Uskov Grigorova et al. 2012. Passive targeting of ischemic-reperfused myocardium with adenosine-loaded silica nanoparticles. Int J Nanomedicine 7:1671-1678.
10. Ganesh N, Jayakumar R, Koyakutty M, Mony U, Nair SV. 2012. Embedded Silica Nanoparticles in Poly(Caprolactone) Nanofibrous Scaffolds Enhanced Osteogenic Potential for Bone Tissue Engineering. Tissue Eng Part A 18:1867-1881.
11. Gonçalves AS, Macedo AS, Souto EB. 2012. Therapeutic nanosystems for oncology nanomedicine. Clin Transl Oncol 14:883-890.
12. Guadagnini R, Halamoda B, Cartwright L, Pojana G, Magdolenova Z, Bilanicova D, et al. 2015. Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests. Nanotoxicology 9(S1):13-24.
13. Hondow N, Brydson R, Wang P, Holton MD, Brown MR, Rees P, et al. 2012. Quantitative characterization of nanoparticle agglomeration within biological media. J Nanopart Res 14:977.
14. Jaganathan H, Godin B. 2012. Biocompatibility assessment of Si-based nano- and micro-particles. Adv Drug Deliv Rev 64:1800-1819.
15. Johnston H, Brown D, Kermanizadeh A, Gubbins E, Stone V. 2012. Investigating the relationship between nanomaterial hazard and physicochemical properties: Informing the exploitation of nanomater-ials within therapeutic and diagnostic applications. J Control Release 164:307-313.
16. Larsen LG, Clausen HV, Andersen B, Græm N. 1995. A stereologic study of postmature placentas fixed by dual perfusion. Am J Obstet Gynecol 172:500-507.
17. Lee S, Yun H-S, Kim S-H. 2011. The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis. Biomaterials 32:9434-9443.
18. Lesniak A, Fenaroli F, Monopoli MP, Aberg C, Dawson KA, Salvati A. 2012. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano 6:5845-5857.
19. Mamaeva V, Sahlgren C, Lindén M. 2012. Mesoporous silica nanopar-ticles in medicine-Recent advances. Adv Drug Deliv Rev; epub ahead of print.
20. Mathiesen L, Mose T, Mørck TJ, Nielsen JKS, Nielsen LK, Maroun LL, et al. 2010. Quality assessment of a placental perfusion protocol. Reprod Toxicol 30:138-146.
21. Menjoge AR, Rinderknecht AL, Navath RS, Faridnia M, Kim CJ, Romero R, et al. 2011. Transfer of PAMAM dendrimers across human placenta: Prospects of its use as drug carrier during pregnancy. J Control Release 150:326-338.
22. Mitra P, Audus KL. 2009. Expression and functional activities of selected sulfotransferase isoforms in BeWo cells and primary cytotrophoblast cells. Biochem Pharmacol 78:1475-1482.
23. Mose T, Kjaerstad MB, Mathiesen L, Nielsen JB, Edelfors S, Knudsen L. 2008. Placental Passage of Benzoic acid, Caffeine, and Glyphosate in an Ex Vivo Human Perfusion System. J Toxicol Environ Health A 71: 984-991.
24. Mose T, Mortensen GK, Hedegaard M, Knudsen LE. 2007. Phthalate monoesters in perfusate from a dual placenta perfusion system, the placenta tissue and umbilical cord blood. Reprod Toxicol 23:83-91.
25. Myllynen P, Loughran M, Howard C, Sormunen R, Walsh A, Vähäkangas K. 2008. Kinetics of gold nanoparticles in the human placenta. Reprod Toxicol 26:130-137.
26. Myllynen P, Mathiesen L, Weimer M, Annola K, Immonen E, Karttunen V, et al. 2010. Preliminary interlaboratory comparison of the ex vivo dual human placental perfusion system. Reprod Toxicol 30:94-102.
27. Mørck TJ, Sorda G, Bechi N, Rasmussen BS, Nielsen JB, Ietta F, et al. 2010. Placental transport and in vitro effects of Bisphenol A. Reprod Toxicol 30:131-137.
28. Poulsen MS, Rytting E, Mose T, Knudsen LE. 2009. Modeling placental transport: correlation of in vitro BeWo cell permeability and ex vivo human placental perfusion. Toxicol In Vitro 23:1380-1386.
29. Rytting E, Ahmed MS. 2013. Fetal drug therapy. In: Mattison DR, Editor. Clinical pharmacology during pregnancy. London: Elsevier. pp. 55-72.
30. Rytting E, Bryan J, Southard M, Audus KL. 2007. Low-affinity uptake of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methyl-pyridinium iodide (4-Di-1-ASP) in BeWo cells. Biochem Pharmacol 73:891-900.
31. Sandhiya S, Dkhar SA, Surendiran A. 2009. Emerging trends of nanomedicine - an overview. Fundam Clin Pharmacol 23:263-269.
32. Saunders M. 2009. Transplacental transport of nanomaterials. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1:671-684.
33. Shi J, Karlsson HL, Johansson K, Gogvadze V, Xiao L, Li J, et al. 2012. Microsomal Glutathione Transferase 1 Protects Against Toxicity Induced by Silica Nanoparticles but Not by Zinc Oxide Nanoparticles. ACS Nano 6:1925-1938.
34. Slowing I, Viveroescoto J, Wu C, Lin V. 2008. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 60:1278-1288.
35. Stępnik M, Arkusz J, Smok-Pieniązek A, Bratek-Skicki A, Salvati A. Lynch I, Dawson KA, Gromadzińska J, de Jong WH, Rydzyński K, 2012. Cytotoxic effects in 3T3-L1 mouse and WI-38 human fibroblasts following 72hour and 7day exposures to commercial silica nanopar-ticles. Toxicol Appl Pharmacol 263:89-101.
36. Syme MR, Paxton JW, Keelan JA. 2004. Drug transfer and metabolism by the human placenta. Clin pharmacokinet 43:487-514.
37. Tsutsumi Y, Yoshioka Y. 2011. Quantifying the biodistribution of nanoparticles. Nat Nanotechnol 6:755-755.
38. Wick P, Malek A, Manser P, Meili D, Maeder-Althaus X, Diener L, et al. 2010. Barrier capacity of human placenta for nanosized materials. Environ Health Perspect 118:432-436.
39. Yamashita K, Yoshioka Y, Higashisaka K, Mimura K, Morishita Y, Nozaki M, et al. 2011. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat Nanotechnol 6:321-328.